Key Account Manager (KAM) - Rare Disease - Pediatric Endocronology (North, South, East, West)

Egetis Therapeutics AB

37d

About The Position

The Key Account Manager (KAM) plays a vital role in advancing Egetis’s mission to bring transformative therapies to individuals living with rare diseases. Operating within a small, agile, and resourceful organization, the KAM will help drive the successful U.S. launch and commercial growth of Egetis products. In this highly visible and strategic role, the KAM serves as the business leader for their territory—partnering with healthcare professionals and treatment centers to increase disease awareness, identify patients, and facilitate access to therapy. Key customers include Children’s Hospitals with a focus in Pediatric Endocrinology, Pediatric Neurology, and Genetics. Success in this position requires an entrepreneurial mindset, strong account management skills, and the ability to navigate a dynamic environment with limited resources. The KAM will collaborate cross-functionally to execute launch plans, provide insights that shape commercial strategy, and deliver meaningful impact to patients and the communities they serve.

Requirements

Bachelor’s degree required
10+ years of pharmaceutical or biotech sales experience required
Experience in rare or ultra-rare disease is required with demonstrated ability to navigate very low-prevalence, low awareness markets.
Proven success operating independently within a large geographic territory with limited resources, acting as a primary business owner for the region
Strong clinical understanding and ability to engage credibly with academic specialists
High level of comfort with ambiguity, travel intensity, and direct leadership exposure
Patient centric with high ethical standards
Demonstrating a high level of cross functional collaboration.
Solid understanding of US legal, regulatory and compliance requirements

Nice To Haves

Prior first-launch or early-stage biotech experience is preferred
Experience with selling in Children’s Hospital’s, pediatric endocrinology and/or neurology is preferred

Responsibilities

Identify, prioritize and establish deep relationships with target pediatric endocrinology and neurology centers and referral sites for Egetis product, including leading the transition of patients from early access to commercial product
Execute pre-launch and launch activities across assigned targeted HCP and accounts to driver appropriate awareness, adoption and sustained utilization of Egetis therapies.
Lead disease state education efforts, including diagnostic testing, across all customer stakeholders in a very low-prevalence and low-awareness market environment
Lead comprehensive patient finding/identification efforts by combining targeted disease education, sophisticated use of ICD-10/CPT Code and claims/EMR data and navigation of complex HCP referral patterns
Develop and execute detailed territory plans including individual key customer strategies and tactics, leveraging data and insights to continuously refine priorities and resource allocation.
Position Egetis as a long-term partner withing the rare diseases community. Educate all customer stakeholders on the services and support that Egetis provides to accounts and to the patient community, including but not limited to market access support, patient services programs and disease education initiatives.
Demonstrate cross functional leadership by working closely and collaboratively with Marketing, Medical Affairs, Market Access, Patient Services, Business Operations and Senior Leadership
Provide rapid, structured field insights to shape launch strategies, materials, and support programs and actively participate in internal decision making forums to inform strategy, well beyond traditional sales responsibilities
Own territory business performance by tracking and managing key metrics (e.g., patient starts, account activation, and other agreed KPIs) and maintaining accurate, timely documentation in CRM and other reporting tools.
Help establish field norms and launch playbooks for the organization
Maintain high compliance standards despite startup pace and ambiguity